When to Recheck Hemoglobin After Starting Ferrous Sulfate
Recheck hemoglobin at 2 weeks after initiating oral ferrous sulfate therapy, with the expectation of at least a 1 g/dL increase; if this response is not achieved, reassess for nonadherence, malabsorption, or ongoing blood loss. 1
Initial Response Assessment (2 Weeks)
The most recent AGA expert review explicitly states that in anemic patients, hemoglobin levels should increase by 1 g/dL within 2 weeks of supplementation 1. This 2-week checkpoint serves as a critical early indicator of treatment response and helps identify patients who may need escalation to intravenous iron.
Recent research supports this timeline, demonstrating that:
- Patients receiving daily oral iron (60-120 mg elemental iron) show mean hemoglobin increases of 1.0-1.4 g/dL by week 2 2
- Those receiving alternate-day dosing show slightly lower increases (0.69 g/dL) at 2 weeks 2
One-Month Follow-Up
If the 2-week response is adequate, recheck at 1 month to confirm continued improvement. The 2020 AGA guideline notes that "a response (with improvements in hemoglobin concentration) to oral iron supplementation is typically evident within 1 month of treatment" 3. This timeframe allows assessment of:
- Sustained hemoglobin improvement
- Rising ferritin levels (should begin increasing within a month) 1
- Treatment adherence and tolerability
Three-Month Assessment
Complete the evaluation at 3 months to assess:
- Full anemia correction (target hemoglobin ≥12 g/dL in women, ≥13 g/dL in men)
- Iron store repletion (ferritin should normalize)
- Need for continued maintenance therapy
Research demonstrates that by 3 months, mean hemoglobin increases of 3-4 g/dL are typical with adherent oral iron therapy 2, 4.
When to Escalate to IV Iron
If hemoglobin fails to increase by 1 g/dL at 2 weeks, or ferritin does not rise within 1 month in adherent patients, switch to intravenous iron. 1 This lack of response indicates:
- True nonadherence (often due to gastrointestinal side effects occurring in 12-31% of patients) 1
- Malabsorption (post-bariatric surgery, inflammatory bowel disease, celiac disease)
- Ongoing blood loss exceeding oral iron absorption capacity 3
Common Pitfalls to Avoid
- Don't wait 3 months to assess response - The 2-week checkpoint identifies treatment failures early and prevents prolonged ineffective therapy
- Don't assume nonadherence without checking - Malabsorption and ongoing blood loss are equally important causes of treatment failure 3
- Don't continue oral iron indefinitely without response - This delays appropriate escalation to IV iron, which achieves dramatically superior iron store repletion (ferritin increases 47-fold greater than oral iron) 5
Dosing Context
The question specifies 325 mg ferrous sulfate tablets (approximately 65 mg elemental iron per tablet 6), taken daily. While the historical recommendation was 150-200 mg elemental iron daily, recent evidence suggests lower daily doses or alternate-day dosing may improve tolerability without significantly compromising efficacy 3. However, daily dosing produces faster initial hemoglobin response (≥1 g/dL at 2 weeks) compared to alternate-day dosing 2.